CONFIDENTIAL — APPROVED FOR PUBLIC RELEASE · BUREAU FILE COPY RECORDS CURRENT AS OF 29 MAY 2026 · DISTRIBUTION: UNRESTRICTED
VendorInvestigator Independent Testing Bureau · Public Records Division
DOCKET YEAR 2026 · VOL. II
35,156 SAMPLES ON FILE
No fee · No favor
Compound Evidence File
#EC-2026-0501

KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg

Filed under Peptides. The bureau holds 239 laboratory returns for this compound from 100 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.

Cross-Index

Subjects Shipping This Compound

100 SUBJECTS
SubjectGradeSamplesMeanMinMaxFirst seenLast seen
Tianjin Finder Chemical TFCCASE #VI-2026-0693 A 6 10.0 9.9 10.0 14 Nov 2025 16 Apr 2026
WuXi TIDESCASE #VI-2026-0335 A 5 10.0 9.9 10.0 2 Mar 2026 23 Jun 2026
Hubei JianxiangCASE #VI-2026-0048 A 4 10.0 9.9 10.0 5 Jan 2026 6 Jul 2026
Shanghai Wibson BiotechnologyCASE #VI-2026-0379 A 4 10.0 9.9 10.0 24 Nov 2025 9 Jul 2026
Mokemei BiotechnologyCASE #VI-2026-0540 A 3 10.0 9.9 10.0 14 Feb 2026 14 Jul 2026
PolyPeptide GroupCASE #VI-2026-0143 A 3 10.0 9.9 10.0 13 Apr 2026 24 Jun 2026
SinoPepCASE #VI-2026-0387 A 3 10.0 9.9 10.0 3 Mar 2026 12 Jul 2026
JEEP PeptidesCASE #VI-2026-0457 A 2 10.0 10.0 10.0 13 Jan 2026 7 Jul 2026
Thermo Fisher ScientificCASE #VI-2026-0142 A 2 10.0 10.0 10.0 25 Feb 2026 24 Jun 2026
Bulk Peptide WholesaleCASE #VI-2026-0319 X 1 10.0 10.0 10.0 9 Jun 2025 9 Jun 2025
HomopeptideCASE #VI-2026-0760 A 5 9.9 9.9 10.0 21 May 2026 21 May 2026
Sangon BioCASE #VI-2026-0671 A 4 9.9 9.9 10.0 23 Nov 2025 22 Jun 2026
QYAOBIOCASE #VI-2026-0861 A 4 9.9 9.9 10.0 11 Jan 2026 25 Jun 2026
Hybio PharmaceuticalCASE #VI-2026-0065 A 4 9.9 9.9 10.0 10 Feb 2026 3 Aug 2026
GenScript PeptidesCASE #VI-2026-0860 A 4 9.9 9.9 10.0 5 Apr 2026 17 Aug 2026
Sigma-AldrichCASE #VI-2026-0829 A 4 9.9 9.9 10.0 9 Apr 2026 11 Aug 2026
AsymchemCASE #VI-2026-0091 A 4 9.9 9.9 10.0 19 Feb 2026 9 Jul 2026
AmbioPharmCASE #VI-2026-0177 A 4 9.9 9.9 10.0 11 Mar 2026 18 Aug 2026
Shanghai ERP BiotechnologyCASE #VI-2026-0936 A 2 9.9 9.9 10.0 19 May 2026 25 May 2026
BachemCASE #VI-2026-0314 A 2 9.9 9.9 9.9 10 Mar 2026 3 Apr 2026
Kerui PeptidesCASE #VI-2026-0626 A 2 9.9 9.9 10.0 7 Jan 2026 23 Feb 2026
Flourishglobal PeptideCASE #VI-2026-0630 A 2 9.9 9.9 10.0 23 Jan 2026 12 Jul 2026
Chinese Peptide CompanyCASE #VI-2026-0184 A 2 9.9 9.9 10.0 18 Feb 2026 17 Apr 2026
Shanghai Sigma AudleyCASE #VI-2026-0505 A 2 9.9 9.9 9.9 21 Jun 2026 21 Jul 2026
Lux Synth AminosCASE #VI-2026-0700 X 1 9.5 9.5 9.5 27 Feb 2025 27 Feb 2025
Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 A 8 9.0 7.5 9.9 24 May 2026 24 May 2026
HealthTide BiotechCASE #VI-2026-0955 X 1 9.0 9.0 9.0 8 Jul 2025 8 Jul 2025
Shanghai Sigma Audley SSACASE #VI-2026-0486 A 7 8.9 7.8 10.0 23 May 2026 23 May 2026
Precision Peptide CoCASE #VI-2026-0559 X 1 8.8 8.8 8.8 16 Mar 2025 16 Mar 2025
PeptidologyCASE #VI-2026-0520 X 1 8.6 8.6 8.6 2 Jul 2025 2 Jul 2025
Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 A 8 8.5 6.3 10.0 24 May 2026 24 May 2026
Qingdao Sigma Chemical QSCCASE #VI-2026-0538 A 5 8.3 7.7 9.0 24 May 2026 24 May 2026
Haikou Mingheng TechnologyCASE #VI-2026-0250 X 1 8.3 8.3 8.3 24 Apr 2025 24 Apr 2025
Aavant ResearchCASE #VI-2026-0831 X 1 8.3 8.3 8.3 3 Jun 2025 3 Jun 2025
Yiwu Aozuo Trading CoCASE #VI-2026-0798 X 8 8.2 5.5 10.0 7 May 2025 25 May 2026
LSPLCASE #VI-2026-0523 X 2 8.1 7.6 8.6 14 Jan 2025 26 Jan 2026
Glbiochem (Shanghai)CASE #VI-2026-0704 A 8 8.0 7.2 8.7 24 May 2026 24 May 2026
LiliPeptideCASE #VI-2026-0695 X 8 8.0 6.3 10.0 9 Jun 2025 24 May 2026
Accelerate LabsCASE #VI-2026-0686 X 2 8.0 6.1 9.9 25 Apr 2025 20 May 2026
NUPEPS PeptidesCASE #VI-2026-0896 X 1 7.8 7.8 7.8 6 May 2025 6 May 2025
Yabang PeptideCASE #VI-2026-0148 X 1 7.7 7.7 7.7 13 Jun 2025 13 Jun 2025
Rayshine Peptide BiochemicalsCASE #VI-2026-0545 X 1 7.6 7.6 7.6 16 Mar 2025 16 Mar 2025
NextechLabsCASE #VI-2026-0285 X 1 7.6 7.6 7.6 3 Jun 2025 3 Jun 2025
Quenna PMQCASE #VI-2026-0415 X 1 7.6 7.6 7.6 16 Mar 2025 16 Mar 2025
ScienceCASE #VI-2026-0636 X 1 7.6 7.6 7.6 2 Apr 2025 2 Apr 2025
Bulk Peptide SupplyCASE #VI-2026-0446 X 1 7.5 7.5 7.5 28 Mar 2025 28 Mar 2025
PeptiAtlasCASE #VI-2026-0739 X 1 7.5 7.5 7.5 7 May 2025 7 May 2025
Wolverine PeptidesCASE #VI-2026-0262 X 1 7.4 7.4 7.4 21 May 2025 21 May 2025
Shandong Aishi BiotechnologyCASE #VI-2026-0308 X 1 7.3 7.3 7.3 24 Apr 2025 24 Apr 2025
Paradigm PeptideCASE #VI-2026-0759 X 1 7.3 7.3 7.3 3 Jun 2025 3 Jun 2025
Biolongevity LabsCASE #VI-2026-0442 X 2 7.2 6.7 7.6 20 Jun 2025 24 May 2026
Reta-PeptideCASE #VI-2026-0756 X 12 7.1 5.4 9.1 25 Apr 2025 26 Jan 2026
Peptide TechnologiesCASE #VI-2026-0694 X 1 7.1 7.1 7.1 6 May 2025 6 May 2025
Shanghai Wibson Biotechnology WBSCASE #VI-2026-0214 X 1 7.1 7.1 7.1 14 Jan 2025 14 Jan 2025
OmegAminoCASE #VI-2026-0014 X 1 6.7 6.7 6.7 28 Mar 2025 28 Mar 2025
The Naughty NeedleCASE #VI-2026-0432 X 1 6.7 6.7 6.7 27 Feb 2025 27 Feb 2025
Peptide HavenCASE #VI-2026-0898 X 1 6.6 6.6 6.6 3 Jul 2025 3 Jul 2025
Shanxi Qianyecao Biotech QYCCASE #VI-2026-0189 X 6 6.5 5.2 8.7 11 Jun 2025 19 Jan 2026
Heman Peptide HMCASE #VI-2026-0089 X 1 6.5 6.5 6.5 3 Jul 2025 3 Jul 2025
Hangzhou Mandy BiotechnologyCASE #VI-2026-0695 X 1 6.5 6.5 6.5 28 Mar 2025 28 Mar 2025
HXNetCASE #VI-2026-0061 X 2 6.4 6.3 6.5 8 Jul 2025 21 May 2026
Richards Biotech Simply RichardsCASE #VI-2026-0307 X 1 6.4 6.4 6.4 17 Dec 2024 17 Dec 2024
TSC Top Supplements ChinaCASE #VI-2026-0523 X 9 6.3 4.3 9.2 20 Jun 2025 23 May 2026
M-PeptidesCASE #VI-2026-0442 X 1 6.3 6.3 6.3 11 Jun 2025 11 Jun 2025
Alimo PeptideCASE #VI-2026-0524 X 1 6.3 6.3 6.3 3 Jun 2025 3 Jun 2025
Biolabshop LimitedCASE #VI-2026-0832 X 1 6.2 6.2 6.2 11 Jun 2025 11 Jun 2025
Huaian Hanyou PeptideCASE #VI-2026-0297 X 1 6.2 6.2 6.2 6 May 2025 6 May 2025
Hebei Rimao TechnologyCASE #VI-2026-0529 X 1 6.2 6.2 6.2 3 Jun 2025 3 Jun 2025
Peptide WorldwideCASE #VI-2026-0217 X 1 6.0 6.0 6.0 9 Jun 2025 9 Jun 2025
Pure RawzCASE #VI-2026-0767 X 1 6.0 6.0 6.0 20 Jun 2025 20 Jun 2025
SRY LabsCASE #VI-2026-0657 X 5 5.9 4.5 8.8 16 Mar 2025 24 May 2026
Xingtai Pukelai Technology CoCASE #VI-2026-0850 X 1 5.8 5.8 5.8 28 Mar 2025 28 Mar 2025
Welon Peptide SolutionsCASE #VI-2026-0478 X 1 5.8 5.8 5.8 21 May 2025 21 May 2025
Zenith Jove Peptide ZJCASE #VI-2026-0570 X 2 5.7 5.2 6.1 28 Mar 2025 21 May 2026
Dragon PharmaCASE #VI-2026-0519 X 1 5.6 5.6 5.6 17 Dec 2024 17 Dec 2024
Laicuinuo LCNCASE #VI-2026-0223 X 1 5.6 5.6 5.6 25 Apr 2025 25 Apr 2025
ZhuoYan labCASE #VI-2026-0902 X 1 5.5 5.5 5.5 13 Feb 2025 13 Feb 2025
Paramount PeptidesCASE #VI-2026-0550 X 2 5.4 4.6 6.3 9 Jun 2025 21 May 2026
Xianhong Tong XHT PeptidesCASE #VI-2026-0997 X 1 4.8 4.8 4.8 14 Jan 2025 14 Jan 2025
Zhejiang Yichenkang BiotechnologyCASE #VI-2026-0269 X 3 4.6 4.4 4.9 25 Apr 2025 20 May 2026
Peptides 4 ResearchCASE #VI-2026-0511 X 2 4.5 1.9 7.0 7 May 2025 25 May 2026
Limitless Life NootropicsCASE #VI-2026-0980 X 2 4.3 4.0 4.6 11 Jun 2025 26 Jan 2026
CellupepCASE #VI-2026-0888 X 1 4.3 4.3 4.3 2 Apr 2025 2 Apr 2025
Qingdao VitaConin International TradingCASE #VI-2026-0504 X 1 4.3 4.3 4.3 16 Mar 2025 16 Mar 2025
Bio PepzCASE #VI-2026-0436 X 1 4.3 4.3 4.3 6 May 2025 6 May 2025
Shanghai OuDaXin New Material Technology CenterCASE #VI-2026-0498 E 2 4.2 2.9 5.4 14 Jan 2025 26 Jan 2026
Alpha-GenCASE #VI-2026-0905 X 2 4.2 4.1 4.3 2 Jul 2025 24 May 2026
Champion PeptideCASE #VI-2026-0909 X 1 4.1 4.1 4.1 16 Mar 2025 16 Mar 2025
Prime PeptidesCASE #VI-2026-0696 X 1 3.8 3.8 3.8 6 May 2025 6 May 2025
PurePeptidesCASE #VI-2026-0234 X 1 3.8 3.8 3.8 25 Apr 2025 25 Apr 2025
Amplified AminoCASE #VI-2026-0748 X 1 3.8 3.8 3.8 21 May 2025 21 May 2025
Shenzhen Jiechuang TradingCASE #VI-2026-0292 X 1 3.3 3.3 3.3 3 Jul 2025 3 Jul 2025
WllyBIOCASE #VI-2026-0470 X 1 2.8 2.8 2.8 16 Mar 2025 16 Mar 2025
HK Fat CatCASE #VI-2026-0376 X 1 1.4 1.4 1.4 20 Jun 2025 20 Jun 2025
SubQ SocietyCASE #VI-2026-0716 X 1 0.1 0.1 0.1 20 Jun 2025 20 Jun 2025
PRIVATECASE #VI-2026-0635 X 1 0.0 0.0 0.0 3 Jun 2025 3 Jun 2025
Hebei Chengtong TechnologyCASE #VI-2026-0520 X 1 0.0 0.0 0.0 14 Jan 2025 14 Jan 2025
Wuhan Newtop BiotechCASE #VI-2026-0676 X 1 0.0 0.0 0.0 17 Dec 2024 17 Dec 2024
Weifang Xingbei International TradeCASE #VI-2026-0766 X 1 0.0 0.0 0.0 28 Mar 2025 28 Mar 2025
Explicit SarmsCASE #VI-2026-0017 X 1 0.0 0.0 0.0 11 Jun 2025 11 Jun 2025

Open any subject to view the batch-level evidence for KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg alone.